BWAY
Brainsway LtdNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$586.56M
P/E Ratio
66.50
EPS
$0.22
Beta
0.15
52W High
$17.35
52W Low
$5.41
50-Day MA
$15.29
200-Day MA
$11.18
Dividend Yield
—
Profit Margin
15.60%
Forward P/E
34.97
PEG Ratio
—
About Brainsway Ltd
Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company is headquartered in Jerusalem, Israel.
Fundamentals
| Revenue (TTM) | $56.22M |
| Gross Profit (TTM) | $42.45M |
| EBITDA | $6.62M |
| Operating Margin | 12.90% |
| Return on Equity | 12.60% |
| Return on Assets | 3.31% |
| Revenue/Share (TTM) | $1.47 |
| Book Value | $1.99 |
| Price-to-Book | 7.77 |
| Price-to-Sales (TTM) | 10.43 |
| EV/Revenue | 9.47 |
| EV/EBITDA | 49.45 |
| Quarterly Earnings Growth (YoY) | 200.00% |
| Quarterly Revenue Growth (YoY) | 34.60% |
| Shares Outstanding | $40.09M |
| Float | $26.59M |
| % Insiders | 6.03% |
| % Institutions | 29.84% |
Historical Volatility
HV 10-Day
50.36%
HV 20-Day
51.92%
HV 30-Day
45.43%
HV 60-Day
52.38%
HV Rank
19.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($16.67 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026